Phathom Pharmaceuticals, Inc. PHAT Interest Income
Interest Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s interest income?
- Phathom Pharmaceuticals, Inc. (PHAT) reported interest income of $1.74M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s interest income changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s interest income decreased by 34.2% year-over-year, from $2.64M to $1.74M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s interest income?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s interest income has grown at a 262.0% compound annual growth rate (CAGR), from $41K to $7.04M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.